Patient’s psychological experiences during and after recovery from COVID-19 pandemic: a phenomenological study in Pakistan.

Publication date: Jan 28, 2025

COVID-19 is a transmissible and infectious disease with symptoms similar to pneumonia, ranging from moderate to severe. This study investigated the psychological experiences of patients both during their illness and after their recovery. The study employed purposive sampling and semi-structured interviews to gather insights from 13 COVID-19 survivors (7 women and 6 men). Interpretive Phenomenological Analysis was used to analyze the interview transcripts. Participants ranged in age from 22 to 62 years. The analysis identified seven main themes of psychological experiences during the illness, each with several sub-themes. Key themes included denial of the disease, uncertainty about the illness, and psychological distress, which had sub-themes of depression and stress. Other themes included death anxiety, perceived social stigma (with loneliness as a sub-theme), exposure to infection (with restrictions as a sub-theme), and coping strategies (which encompassed active coping and avoidant coping). For experiences post-recovery, two main themes emerged, with eight sub-themes. The first was post-traumatic growth, which included attachment to God, acceptance of death, gratitude (toward God), trust in interpersonal relationships, gratitude toward people, and the significance of life. The second theme was delayed resilience, which involved recovery from insomnia and post-COVID psychological distress. The study concluded that surviving COVID-19 involves significant psychological challenges both during the illness and after recovery. These insights are valuable for psychologists and counselors in addressing the emotional and mental health needs of COVID-19 patients.

Open Access PDF

Concepts Keywords
Counselors Coping
Death Fears
Infectious Interpersonal relationships
Pakistan Loneliness
Pneumonia Post-traumatic growth
Resilience

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease MESH infectious disease
pathway REACTOME Infectious disease
disease MESH pneumonia
disease MESH uncertainty
disease MESH psychological distress
disease MESH depression
disease MESH death
disease MESH anxiety
disease MESH social stigma
disease MESH loneliness
disease MESH infection
disease MESH insomnia
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH cough headache
drug DRUGBANK Oxygen
disease MESH restlessness
disease MESH shock
disease IDO infectivity
disease MESH emotional exhaustion
disease MESH Emotional disturbances
drug DRUGBANK Etoperidone
disease MESH lifestyles
drug DRUGBANK Cysteamine
disease IDO history
disease MESH Marital Status
drug DRUGBANK Riboprine
disease MESH psychological stress
disease IDO process
drug DRUGBANK Ademetionine
disease MESH psychological well being
drug DRUGBANK Creatinolfosfate
disease MESH chronic conditions
disease MESH anxiety disorders
drug DRUGBANK Methylergometrine
drug DRUGBANK Trestolone
drug DRUGBANK (S)-Des-Me-Ampa
disease MESH leprosy
disease MESH Middle East Respiratory Syndrome
disease MESH Posttraumatic stress disorder
disease MESH morbidity
disease MESH emergency
disease MESH mental disorders
disease MESH hypochondriasis
drug DRUGBANK BIA

Original Article

(Visited 2 times, 1 visits today)